152 related articles for article (PubMed ID: 11169515)
1. Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading.
Kruse AJ; Baak JP; de Bruin PC; Jiwa M; Snijders WP; Boodt PJ; Fons G; Houben PW; The HS
J Pathol; 2001 Jan; 193(1):48-54. PubMed ID: 11169515
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the presence of oncogenic HPV DNA assessed by polymerase chain reaction and Ki-67 immunoquantitative features in cervical intraepithelial neoplasia.
Kruse AJ; Baak JP; de Bruin PC; van de Goot FR; Kurten N
J Pathol; 2001 Dec; 195(5):557-62. PubMed ID: 11745691
[TBL] [Abstract][Full Text] [Related]
3. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables.
Kruse AJ; Baak JP; Janssen EA; Bol MG; Kjellevold KH; Fianne B; Lovslett K; Bergh J
J Pathol; 2003 Apr; 199(4):462-70. PubMed ID: 12635137
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection.
Mimica M; Tomić S; Kardum G; Hofman ID; Kaliterna V; Pejković L
Int J Gynecol Cancer; 2010 Jan; 20(1):116-9. PubMed ID: 20130511
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prospective, routine application of Ki-67 immunoquantitation in early CIN for assessment of short-term progression risk.
Kruse AJ; Gudlaugsson E; Helliesen T; Janssen EA; van Diermen B; Sandvik S; Baak JP
Anal Quant Cytol Histol; 2004 Jun; 26(3):134-40. PubMed ID: 15218689
[TBL] [Abstract][Full Text] [Related]
6. Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability.
Kruse AJ; Skaland I; Janssen EA; Buhr-Wildhagen S; Klos J; Arends MJ; Baak JP
Int J Gynecol Pathol; 2004 Apr; 23(2):100-9. PubMed ID: 15084837
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
Alshenawy HA
Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
[TBL] [Abstract][Full Text] [Related]
8. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR
Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia.
Kruse AJ; Baak JP; Helliesen T; Kjellevold KH; Bol MG; Janssen EA
Am J Surg Pathol; 2002 Nov; 26(11):1501-7. PubMed ID: 12409727
[TBL] [Abstract][Full Text] [Related]
10. Is the expression pattern of BD ProExC the same as Ki-67? A comparative analysis in cervical biopsies.
Walts AE; Bose S
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):262-7. PubMed ID: 19875954
[TBL] [Abstract][Full Text] [Related]
11. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis.
Qiao X; Bhuiya TA; Spitzer M
J Low Genit Tract Dis; 2005 Apr; 9(2):100-7. PubMed ID: 15870531
[TBL] [Abstract][Full Text] [Related]
12. Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model.
Kruse AJ; Baak JP; Janssen EA; Kjellevold KH; Fiane B; Lovslett K; Bergh J; Robboy S
Cell Oncol; 2004; 26(1-2):13-20. PubMed ID: 15371653
[TBL] [Abstract][Full Text] [Related]
13. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
14. Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias.
Mandal R; Ghosh I; Banerjee D; Mittal S; Muwonge R; Roy C; Panda C; Vernekar M; Frappart L; Basu P
Int J Gynecol Pathol; 2020 Jul; 39(4):384-390. PubMed ID: 32515923
[TBL] [Abstract][Full Text] [Related]
15. Histology of cervical intraepithelial neoplasia and the role of biomarkers.
Martin CM; O'Leary JJ
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):605-15. PubMed ID: 21636328
[TBL] [Abstract][Full Text] [Related]
16. The role of p-STAT3 (ser727) revealed by its association with Ki-67 in cervical intraepithelial neoplasia.
Yang SF; Yuan SS; Yeh YT; Wu MT; Su JH; Hung SC; Chai CY
Gynecol Oncol; 2005 Sep; 98(3):446-52. PubMed ID: 16005944
[TBL] [Abstract][Full Text] [Related]
17. DISTRIBUTION OF INTRAEPITHELIAL LYMPHOCYTES AND MACROPHAGES IN CERVICAL MICROENVIRONMENT DURING THE PROGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA.
Manjgaladze K; Tevdorashvili G; Alibegashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 Sep; (294):123-128. PubMed ID: 31687963
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and grading of cervical intraepithelial neoplasias].
Rosamilia C; Feichter G; Tzankov A; Obermann EC
Pathologe; 2012 Mar; 33(2):118-23. PubMed ID: 22350168
[TBL] [Abstract][Full Text] [Related]
19. MIB1, a promising marker for the classification of cervical intraepithelial neoplasia.
Bulten J; van der Laak JA; Gemmink JH; Pahlplatz MM; de Wilde PC; Hanselaar AG
J Pathol; 1996 Mar; 178(3):268-73. PubMed ID: 8778331
[TBL] [Abstract][Full Text] [Related]
20. Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women.
Carrilho C; Cirnes L; Alberto M; Buane L; Mendes N; David L
J Clin Pathol; 2005 Jan; 58(1):61-8. PubMed ID: 15623485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
